176 related articles for article (PubMed ID: 30092680)
1. The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis.
Suto T; Yonemoto Y; Okamura K; Sakane H; Takeuchi K; Tamura Y; Kaneko T; Ayabe K; Chikuda H
Mod Rheumatol; 2019 Sep; 29(5):775-781. PubMed ID: 30092680
[No Abstract] [Full Text] [Related]
2. Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study.
Yoshikawa A; Yoshida S; Kimura Y; Tokai N; Fujiki Y; Kotani T; Matsumura Y; Takeuchi T; Makino S
Mod Rheumatol; 2018 Mar; 28(2):227-234. PubMed ID: 28644744
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of iguratimod
Nozaki Y; Inoue A; Kinoshita K; Funauchi M; Matsumura I
Mod Rheumatol; 2020 Mar; 30(2):249-258. PubMed ID: 30676812
[No Abstract] [Full Text] [Related]
4. The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.
Ebina K; Miyama A; Tsuboi H; Kaneshiro S; Nishikawa M; Owaki H; Tsuji S; Hirao M; Etani Y; Goshima A; Hashimoto J; Yoshikawa H
Mod Rheumatol; 2019 Jul; 29(4):581-588. PubMed ID: 29882440
[No Abstract] [Full Text] [Related]
5. Efficacy of the clinical use of iguratimod therapy in patients with rheumatoid arthritis.
Okamura K; Yonemoto Y; Okura C; Kobayashi T; Takagishi K
Mod Rheumatol; 2015 Mar; 25(2):235-40. PubMed ID: 25065917
[TBL] [Abstract][Full Text] [Related]
6. The addition of iguratimod can reduce methotrexate dose in rheumatoid arthritis with clinical remission.
Yoshikawa A; Kotani T; Matsuda S; Hata K; Matsumura Y; Takeuchi T
Mod Rheumatol; 2022 Jan; 32(1):68-73. PubMed ID: 33627038
[TBL] [Abstract][Full Text] [Related]
7. Disease activity early in treatment as a predictor of future low disease activity in RA patients treated with iguratimod.
Yoshioka Y; Takahashi N; Kaneko A; Hirano Y; Kanayama Y; Kanda H; Takagi H; Ito T; Kato T; Saito K; Funahashi K; Asai S; Takemoto T; Terabe K; Asai N; Ishiguro N; Kojima T
Mod Rheumatol; 2016; 26(2):169-74. PubMed ID: 26140467
[TBL] [Abstract][Full Text] [Related]
8. [DMARDs (Focusing on iguratimod)].
Ito S
Nihon Rinsho; 2016 Jun; 74(6):948-54. PubMed ID: 27311184
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis.
Mizutani S; Kodera H; Sato Y; Nanki T; Yoshida S; Yasuoka H
Clin Rheumatol; 2021 Jan; 40(1):123-132. PubMed ID: 32506311
[TBL] [Abstract][Full Text] [Related]
10. Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study.
Ebina K; Hirano T; Maeda Y; Okita Y; Etani Y; Hirao M; Yamamoto W; Hashimoto M; Murata K; Onishi A; Jinno S; Hara R; Son Y; Amuro H; Kotani T; Shiba H; Katayama M; Yamamoto K; Kumanogoh A; Okada S; Nakata K
Mod Rheumatol; 2023 Jul; 33(4):690-699. PubMed ID: 35962543
[TBL] [Abstract][Full Text] [Related]
11. Iguratimod for the treatment of rheumatoid arthritis in Japan.
Tanaka K; Yamaguchi T; Hara M
Expert Rev Clin Immunol; 2015 May; 11(5):565-73. PubMed ID: 25797025
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs.
Hu CJ; Zhang L; Zhou S; Jiang N; Zhao JL; Wang Q; Tian XP; Zeng XF
J Orthop Surg Res; 2021 Jul; 16(1):457. PubMed ID: 34271950
[TBL] [Abstract][Full Text] [Related]
13. Iguratimod in combination with methotrexate in active rheumatoid arthritis : Therapeutic effects.
Xia Z; Lyu J; Hou N; Song L; Li X; Liu H
Z Rheumatol; 2016 Oct; 75(8):828-833. PubMed ID: 26508503
[TBL] [Abstract][Full Text] [Related]
14. Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis.
Xiao W; Guo JP; Li C; Ye H; Wei W; Zou Y; Dai L; Li Z; Zhang M; Li X; Cai X; Zhao J; Wang Y; Tao Y; Liu D; Li Y; Wu M; Sun E; Wu L; Luo L; Mu R; Li Z
Pharmacogenomics; 2018 Apr; 19(5):383-392. PubMed ID: 29517409
[TBL] [Abstract][Full Text] [Related]
15. Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients.
Ishikawa K; Ishikawa J
Mod Rheumatol; 2019 May; 29(3):418-429. PubMed ID: 29798702
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
17. Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.
Ishiguro N; Yamamoto K; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Hara M;
Mod Rheumatol; 2013 May; 23(3):430-9. PubMed ID: 22833377
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.
Hara M; Ishiguro N; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Yamamoto K;
Mod Rheumatol; 2014 May; 24(3):410-8. PubMed ID: 24252050
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.
Hattori K; Hirano Y; Kanayama Y; Hattori Y; Kato T; Takahashi N; Ishiguro N; Kojima T
Mod Rheumatol; 2021 Jan; 31(1):80-87. PubMed ID: 32148143
[TBL] [Abstract][Full Text] [Related]
20. The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care.
Inoue A; Nozaki Y; Hirooka Y; Kinoshita K; Chiba Y; Funauchi M; Matsumura I
Life (Basel); 2020 Oct; 10(11):. PubMed ID: 33138014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]